References
1. Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on
Rhinosinusitis and Nasal Polyps 2020. Rhinology . 2020;58(Suppl
S29):1-464. doi:10.4193/Rhin20.600
2. Hulse KE, Stevens WW, Tan BK, Schleimer RP. Pathogenesis of nasal
polyposis. Clin Exp Allergy . 2015;45(2):328-346.
doi:10.1111/cea.12472
3. Grayson JW, Cavada M, Harvey RJ. Clinically relevant phenotypes in
chronic rhinosinusitis. J of Otolaryngol - Head & Neck Surg .
2019;48(1):23. doi:10.1186/s40463-019-0350-y
4. Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal
Polyps. J Allergy Clin Immunol Pract . 2016;4(4):565-572.
doi:10.1016/j.jaip.2016.04.012
5. Chen S, Zhou A, Emmanuel B, Thomas K, Guiang H. Systematic literature
review of the epidemiology and clinical burden of chronic rhinosinusitis
with nasal polyposis. Current Medical Research and Opinion .
2020;36(11):1897-1911. doi:10.1080/03007995.2020.1815682
6. Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in
Europe - an underestimated disease. A GA2LEN study: Chronic
rhinosinusitis in Europe. Allergy . 2011;66(9):1216-1223.
doi:10.1111/j.1398-9995.2011.02646.x
7. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma,
aspirin intolerance, nasal polyposis and chronic obstructive pulmonary
disease in a population-based study. Int J Epidemiol .
1999;28(4):717-722. doi:10.1093/ije/28.4.717
8. Johansson L, Åkerlund A, Melén I, Holmberg K, Bende M. Prevalence of
Nasal Polyps in Adults: The Skovde Population-Based Study. Ann
Otol Rhinol Laryngol . 2003;112(7):625-629.
doi:10.1177/000348940311200709
9. Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its
association with chronic rhinosinusitis: the GA2LEN survey in Europe.Allergy . 2012;67(1):91-98. doi:10.1111/j.1398-9995.2011.02709.x
10. Langdon C, Mullol J. Nasal polyps in patients with asthma:
prevalence, impact, and management challenges. J Asthma Allergy .
2016;9:45-53. doi:10.2147/JAA.S86251
11. Håkansson K, Bachert C, Konge L, et al. Airway Inflammation in
Chronic Rhinosinusitis with Nasal Polyps and Asthma: The United Airways
Concept Further Supported. PLOS ONE . 2015;10(7):e0127228.
doi:10.1371/journal.pone.0127228
12. Bousquet J, Schünemann HJ, Samolinski B, et al. Allergic Rhinitis
and its Impact on Asthma (ARIA): Achievements in 10 years and future
needs. Journal of Allergy and Clinical Immunology .
2012;130(5):1049-1062. doi:10.1016/j.jaci.2012.07.053
13. Dixon AE, Kaminsky DA, Holbrook JT, Wise RA, Shade DM, Irvin CG.
Allergic Rhinitis and Sinusitis in Asthma. Chest .
2006;130(2):429-435. doi:10.1378/chest.130.2.429
14. van der Veen J, Seys SF, Timmermans M, et al. Real-life study
showing uncontrolled rhinosinusitis after sinus surgery in a tertiary
referral centre. Allergy . 2017;72(2):282-290.
doi:10.1111/all.12983
15. Deal RT, Kountakis SE. Significance of nasal polyps in chronic
rhinosinusitis: symptoms and surgical outcomes. Laryngoscope .
2004;114(11):1932-1935. doi:10.1097/01.mlg.0000147922.12228.1f
16. Mascarenhas JG, da Fonseca VMG, Chen VG, et al. Long-term outcomes
of endoscopic sinus surgery for chronic rhinosinusitis with and without
nasal polyps. Braz J Otorhinolaryngol . 2013;79(3):306-311.
doi:10.5935/1808-8694.20130055
17. Hopkins C, Rudmik L, Lund VJ. The predictive value of the
preoperative Sinonasal Outcome Test-22 score in patients undergoing
endoscopic sinus surgery for chronic rhinosinusitis.Laryngoscope . 2015;125(8):1779-1784. doi:10.1002/lary.25318
18. Rihkanen H, Toppila-Salmi S, Arffman M, Manderbacka K, Keskimäki I,
Hytönen M. Aikuisten sivuontelotulehdusten tähystyskirurgia Suomessa.
Published online 2017. Accessed December 27, 2021.
https://helda.helsinki.fi/handle/10138/298065
19. Gill AS, Smith KA, Meeks H, et al. Asthma increases long‐term
revision rates of endoscopic sinus surgery in chronic rhinosinusitis
with and without nasal polyposis. Int Forum Allergy Rhinol .
2021;11(8):1197-1206. doi:10.1002/alr.22779
20. Rix I, Håkansson K, Larsen CG, Frendø M, von Buchwald C. Management
of Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma: A
Systematic Review. Am J Rhinol�Allergy . 2015;29(3):193-201.
doi:10.2500/ajra.2015.29.4178
21. Quan H, Li B, Couris CM, et al. Updating and Validating the Charlson
Comorbidity Index and Score for Risk Adjustment in Hospital Discharge
Abstracts Using Data From 6 Countries. American Journal of
Epidemiology . 2011;173(6):676-682. doi:10.1093/aje/kwq433
22. Gasparini A. comorbidity: An R package for computing comorbidity
scores. JOSS . 2018;3(23):648. doi:10.21105/joss.00648
23. Nelson WB. Recurrent Events Data Analysis for Product Repairs,
Disease Recurrences, and Other Applications . Society for Industrial and
Applied Mathematics; 2003. doi:10.1137/1.9780898718454
24. R Core Team. R: A Language and Environment for Statistical
Computing . R Foundation for Statistical Computing; 2020.
https://www.R-project.org/
25. Grigoreas C, Vourdas D, Petalas K, Simeonidis G, Demeroutis I,
Tsioulos T. Nasal polyps in patients with rhinitis and asthma.Allergy Asthma Proc . 2002;23(3):169-174.
26. Beule A. Epidemiology of chronic rhinosinusitis, selected risk
factors, comorbidities, and economic burden. GMS Current Topics in
Otorhinolaryngology - Head and Neck Surgery; 14:Doc11 . Published online
December 22, 2015. doi:10.3205/CTO000126
27. Koskinen A, Salo R, Huhtala H, et al. Factors affecting revision
rate of chronic rhinosinusitis. Laryngoscope Investig
Otolaryngol . 2016;1(4):96-105. doi:10.1002/lio2.27
28. Williamson PA, Vaidyanathan S, Clearie K, Barnes M, Lipworth BJ.
Airway dysfunction in nasal polyposis: a spectrum of asthmatic disease?:
Airway dysfunction in nasal polyposis. Clinical & Experimental
Allergy . 2011;41(10):1379-1385. doi:10.1111/j.1365-2222.2011.03793.x
29. Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic
Rhinosinusitis with Nasal Polyps and Asthma. The Journal of
Allergy and Clinical Immunology: In Practice . 2021;9(3):1133-1141.
doi:10.1016/j.jaip.2020.09.063
30. Veloso-Teles R, Cerejeira R. Endoscopic Sinus Surgery for Chronic
Rhinosinusitis with Nasal Polyps: Clinical Outcome and Predictive
Factors of Recurrence. Am J Rhinol�Allergy . 2017;31(1):56-62.
doi:10.2500/ajra.2017.31.4402
31. Loftus CA, Soler ZM, Koochakzadeh S, et al. Revision surgery rates
in chronic rhinosinusitis with nasal polyps: meta‐analysis of risk
factors. Int Forum Allergy Rhinol . 2020;10(2):199-207.
doi:10.1002/alr.22487
32. Lilja MJ, Koskinen A, Virkkula P, et al. Factors Affecting the
Control of Chronic Rhinosinusitis With Nasal Polyps: A Comparison in
Patients With or Without NERD. Allergy�Rhinol (Providence) .
2021;12:215265672110038. doi:10.1177/21526567211003844
33. Penttilä E, Sillanpää S, Vento SI, et al. Eosinophilia, asthma, NERD
and the use of oral corticosteroids predict uncontrolled chronic
rhinosinusitis with nasal polyps after surgery. Asian Pac J
Allergy Immunol . Published online 2022. doi:10.12932/AP-310321-1102
34. Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of Disease
in Chronic Rhinosinusitis with Nasal Polyps. JAA . 2021;Volume
14:127-134. doi:10.2147/JAA.S290424
35. Claeys N, Teeling MT, Legrand P, et al. Patients Unmet Needs in
Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board
Statement of EUFOREA. Front Allergy . 2021;2:761388.
doi:10.3389/falgy.2021.761388
36. Kotisalmi E, Hakulinen A, Mäkelä M, Toppila-Salmi S, Kauppi P. A
comparison of biologicals in the treatment of adults with severe asthma
– real-life experiences. asthma res and pract . 2020;6(1):2.
doi:10.1186/s40733-020-00055-9
37. Bachert C, Hellings PW, Mullol J, et al. Dupilumab improves
patient-reported outcomes in patients with chronic rhinosinusitis with
nasal polyps and comorbid asthma. The Journal of Allergy and
Clinical Immunology: In Practice . 2019;7(7):2447-2449.e2.
doi:10.1016/j.jaip.2019.03.023
38. Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of
dupilumab in patients with severe chronic rhinosinusitis with nasal
polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two
multicentre, randomised, double-blind, placebo-controlled,
parallel-group phase 3 trials. The Lancet .
2019;394(10209):1638-1650. doi:10.1016/S0140-6736(19)31881-1
39. Gevaert P, Omachi TA, Corren J, et al. Efficacy and safety of
omalizumab in nasal polyposis: 2 randomized phase 3 trials.Journal of Allergy and Clinical Immunology . 2020;146(3):595-605.
doi:10.1016/j.jaci.2020.05.032
40. Charles D, Shanley J, Temple S, Rattu A, Khaleva E, Roberts G.
Real‐World Efficacy of Treatment with Benralizumab, Dupilumab,
Mepolizumab and Reslizumab for Severe Asthma: A Systematic Review and
Meta‐analysis. Clin Experimental Allergy . Published online
February 16, 2022:cea.14112. doi:10.1111/cea.14112
41. Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics
for CRSwNP with or without asthma. Allergy .
2019;74(12):2312-2319. doi:10.1111/all.13875